简体中文 | 繁體中文 | English

Products & Services News

2024-06-07 09:44 Tigo Energy Solar Rapid Shutdown Selected by Constructora San Jose for 142MWp Solar System
2024-06-07 09:33 InQuik and CMC Join Forces to Drive Innovation in Bridge Building
2024-06-06 15:53 A Tourism Commission Project: CITY IN TIME
2024-06-06 11:25 Accor & Amadeus announce a new collaboration
2024-06-06 09:57 Kioxia and Xinnor Collaborate to Deliver High Performance PCIe 5.0 NVMe SSD RAID Solution for Enterprise and Data Center Applications
2024-06-06 09:39 Sisvel Campaign Demystifies Patents for Cellular IoT Device Makers
2024-06-05 18:20 Thales Now Provides Complete Passwordless Functionality for Enterprises with Passwordless 360°
2024-06-05 16:11 SES Space & Defense Demonstrates First Multi-orbit, Multi-band Commercial LEO Relay
2024-06-05 15:59 KnowBe4’s Annual Phishing Benchmarking Report Shows Focusing on the Human Element Still the Best Safeguard Against Cyber Threats
2024-06-05 15:27 DEWA Leads in the UAE in Sustainability Perceptions and Brand Value Growth
2024-06-05 10:42 ees Europe: Battery Storage – Powerbanks for the Energy Transition
2024-06-05 10:38 Porsche Motorsport Appoints NetApp as Exclusive Intelligent Data Infrastructure Partner
2024-06-05 10:33 Bio-Sourcing and Afrigen Biologics partner on groundbreaking biomanufacturing platform to improve access to biotherapeutics in South Africa
2024-06-05 10:08 OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology
2024-06-05 10:00 Ceres signs contract with Shell for green hydrogen
2024-06-04 16:26 Mavenir, Qualcomm and EchoStar Achieve Industry-First 5G Open RAN RedCap Demonstration on the Boost Mobile Network
2024-06-04 10:22 Shining Bright atop Taipei 101, GIGABYTE Redefines AI Evolution Accelerated by Next-Generation Computing at COMPUTEX
2024-06-04 10:16 Takeda’s TAK-861 Phase 2b Late-Breaking Data Presentations at SLEEP 2024 Demonstrate Clinically Meaningful Impact of Oral Orexin Agonist in Narcolepsy Type 1 Compared to Placebo
2024-06-04 10:10 PUMA Reveals Global Partnership With HYROX
2024-06-04 10:08 Merck’s Innovative Oncology Pipeline of DNA Damage Response Inhibitors and Antibody-Drug Conjugates Poised to Advance Cancer Treatment